Trexquant Investment’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-43,723
| Closed | -$163K | – | 1923 |
|
|
2024
Q3 | $163K | Sell |
43,723
-9,230
| -17% | -$34.4K | ﹤0.01% | 1455 |
|
|
2024
Q2 | $297K | Sell |
52,953
-36,489
| -41% | -$204K | ﹤0.01% | 1367 |
|
|
2024
Q1 | $469K | Sell |
89,442
-36,840
| -29% | -$193K | 0.01% | 1168 |
|
|
2023
Q4 | $660K | Buy |
126,282
+59,095
| +88% | +$309K | 0.01% | 972 |
|
|
2023
Q3 | $1.06M | Buy |
67,187
+13,910
| +26% | +$219K | 0.03% | 731 |
|
|
2023
Q2 | $1.04M | Buy |
53,277
+38,119
| +251% | +$741K | 0.03% | 744 |
|
|
2023
Q1 | $430K | Buy |
+15,158
| New | +$430K | 0.01% | 1059 |
|
|
2021
Q2 | – | Sell |
-11,027
| Closed | -$460K | – | 1581 |
|
|
2021
Q1 | $460K | Buy |
+11,027
| New | +$460K | 0.04% | 548 |
|
|
2020
Q4 | – | Sell |
-18,954
| Closed | -$805K | – | 1585 |
|
|
2020
Q3 | $805K | Buy |
+18,954
| New | +$805K | 0.05% | 495 |
|
|
2020
Q2 | – | Sell |
-19,739
| Closed | -$908K | – | 1554 |
|
|
2020
Q1 | $908K | Buy |
+19,739
| New | +$908K | 0.07% | 448 |
|
|
2019
Q2 | – | Sell |
-8,753
| Closed | -$442K | – | 1190 |
|
|
2019
Q1 | $442K | Sell |
8,753
-12,652
| -59% | -$639K | 0.03% | 613 |
|
|
2018
Q4 | $862K | Buy |
21,405
+17,897
| +510% | +$721K | 0.05% | 460 |
|
|
2018
Q3 | $243K | Buy |
+3,508
| New | +$243K | 0.02% | 759 |
|